Mini-Focus Issue: Long-Term Outcomes of DESClinical ResearchInfluence of Sex on Long-Term Outcomes After Percutaneous Coronary Intervention With the Paclitaxel-Eluting Coronary Stent: Results of the “TAXUS Woman” Analysis
Key Words
Abbreviations and Acronyms
Cited by (0)
Supported by Boston Scientific Corporation. Dr. Mikhail has been an advisory board member for Boston Scientific for a new stent platform; and she is on the steering committee of a multicenter trial conducted by Abbott Vascular and is a Speakers' Bureau member for Medtronic. Dr. Cox is a Speakers' Bureau member and has received consulting fees from Boston Scientific. Dr. Ellis is a consultant to Abbott Vascular for a new stent platform and has also received consulting fees from Boston Scientific and Cordis. Dr. Lasala is a Speakers' Bureau member and has received honoraria from Boston Scientific and Cordis/Johnson & Johnson. Dr. Ormiston has received research grants and support from Boston Scientific, Johnson & Johnson, Abbott Vascular, and Elixir Medical as well as honoraria from Boston Scientific and Abbott Vascular and is an advisory board member for Boston Scientific, Abbott Vascular, and Devax. Dr. Stone has received research grants from Boston Scientific and Abbott Vascular. Dr. Turco has received research support and consulting fees from and is a Speakers' Bureau member for Abbott, Boston Scientific, and Medtronic. Dr. Joshi is a full-time employee of Boston Scientific. Dr. Baim was a full-time employee and a stockholder of Boston Scientific. Drs. Gerber and Colombo have reported that they have no relationships to disclose. Dr. Baim is deceased.